Table 3 Baseline characteristics, morbidities, complications, outcomes of influenza infection cases treat with or without oseltamivir, 2013-2015
From: Risk of mortality associated with respiratory syncytial virus and influenza infection in adults
Variables | Influenza not treated with Oseltamivir (N = 65) | Influenza treated with Oseltamivir (N = 247) | P value |
|---|---|---|---|
Male, n (%) | 30 (46.2) | 123 (49.8) | 0.60 |
Age (years) mean (SD) | 61.2 (18.3) | 63.0 (16.7) | 0.44 |
Resident of long-term care facilities, n (%) | 1 (1.5) | 5 (2.0) | 0.80 |
Malignancy, n (%) | 6 (9.2) | 26 (10.5) | 0.08 |
Congestive heart failure, n (%) | 8 (12.3) | 15 (6.1) | 0.08 |
Cerebrovascular accident, n (%) | 4 (6.2) | 35 (14.2) | 0.08 |
Chronic kidney disease, n (%) | 8 (12.3) | 30 (12.1) | 0.91 |
Diabetes, n (%) | 23 (35.4) | 57 (23.1) | 0.04 |
Liver disease, n (%) | 5 (7.7) | 20 (8.1) | 0.91 |
Chronic obstructive pulmonary disease, n (%) | 6 (9.2) | 9 (3.6) | 0.06 |
Asthma, n (%) | 6 (9.2) | 14 (5.7) | 0.29 |
Body temperature > 37.5 °C, n (%) | 17 (26.2) | 93 (37.7) | 0.08 |
Pneumonia, n (%) | 19 (29.2) | 59 (23.9) | 0.37 |
Respiratory bacterial superinfection, n (%) | 6 (9.2) | 26 (10.5) | 0.76 |
Hypoxemia, n (%) | 17 (26.2) | 76 (30.8) | 0.47 |
Mechanical ventilation, n (%) | 3 (4.6) | 4 (1.6) | 0.14 |
PSI score, mean (SD) | 85.0 (36.6) | 86.9 (34.5) | 0.70 |
Twenty-day all-cause mortality (%) | 5 (7.7) | 16 (6.5) | 0.72 |
Sixty-day all-cause mortality (%) | 12 (18.5) | 26 (10.5) | 0.09 |